We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Novel Tissue Containment System for Manual Morcellation Lowers Risk of Cancer Cell Spread

By HospiMedica International staff writers
Posted on 02 Nov 2023
Print article
Image: The LapBox is designed for the safe and simple removal of tissue (Photo courtesy of Ark Surgical)
Image: The LapBox is designed for the safe and simple removal of tissue (Photo courtesy of Ark Surgical)

Hysterectomy ranks as the second most frequent surgery performed on women, with one-quarter of these procedures done through open surgery, involving a large cut in the abdomen. Notably, there is a risk as 1 in 350 women having a hysterectomy for presumed benign conditions actually have an undiagnosed malignancy, which could potentially be spread by the process of uncontained morcellation. Now, a novel containment removal system that facilitates safe tissue removal during laparoscopic surgery provides gynecologists with the option to perform manual morcellation with minimal invasion, thus avoiding the risks associated with open surgery.

Ark Surgical’s (Nazareth, Israel) LapBox containment removal system offers a secure, self-contained space for the efficient and quick removal of large tissues during laparoscopic surgeries supporting manual and power morcellation. The LapBox is suitable for myomectomies (the removal of uterine fibroids), hysterectomies (the removal of the whole uterus), cystectomies, and salpingo-oophorectomies.

The LapBox features a unique double-walled design, which ensures a secure, enclosed environment that minimizes the chance of spreading of any cancerous cells that might be present during morcellation. Moreover, its design incorporates a user-friendly technology that enhances the gynecologist's precision and dexterity, improving the overall laparoscopic surgical process. Ark Surgical has received US Food and Drug Administration (FDA) clearance for its patented LapBox tissue containment removal system for manual morcellation.

Related Links:
Ark Surgical 

Platinum Supplier
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Specimen Collection & Transport
Barrier-Free Examination Table
Ritter 244
Gold Supplier
Heavy-Duty Wheelchair Scale
6495 Stationary

Print article


Critical Care

view channel
Image: Investigators are developing synthetic programmable bacteria to help kill cancerous tissue (Photo courtesy of Texas A&M University)

Programmable Bacteria Could Cure Cancer with Single $1 Dose

Cancer treatments have traditionally faced challenges such as harmful side effects, limited patient responsiveness, and high costs. A significant percentage of cancer survivors and patients are burdened... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The patented 3TR technology delivers proven PCR-level sensitivity and specificity (Photo courtesy of 3EO Health)

High-Performing Low-Cost Diagnostic Platform Provides Molecular Results At Near Antigen Pricing

When it comes to point-of-care respiratory diagnostic products, there's often a trade-off between performance and affordability. Current molecular diagnostic solutions are high-performing but expensive... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.